Professor Shaun McColl

Professor Shaun McColl
  • Biography/ Background

    Academic appointments

    1987 –1989:  Arthritis Society of Canada Post-Doctoral Research Fellow, Centre de Recherche en Inflammation, Immunologie et Rhumatologie, Centre de Recherche du CHUL, Université Laval, Québec, Canada.

    1989-1993:  Professeur Adjoint, Department of Physiology, Faculty of Medicine, Université Laval, Québec, Canada

    1992:  Visiting Scientist, Genentech, South San Francisco, USA

    1993:  Visiting Scientist, Molecular Sciences Division, Pfizer Central Research, Groton, Connecticut, USA.

    1993-1995:  Research Fellow, The John Curtin School of Medical Research, Australian National University, Canberra, Australia.

    1995-2000:  Senior Lecturer and Head of Chemokine Biology Laboratory, Department of Microbiology and Immunology, The University of Adelaide, Adelaide, South Australia.

    2000:  Visiting Professor, Biomedical Research Center, University of British Columbia, Vancouver, British Columbia, Canada.

    2002-2003:  Associate Professor and Head of Chemokine Biology, School of Molecular & Biomedical Science, Adelaide University, Adelaide, South Australia.

    2004-present:  Professor of Immunology and Head of Chemokine Biology, School of Molecular & Biomedical Science, The University of Adelaide, Adelaide, South Australia.

    2007:  Visiting Professor, Centre de Recherche en Inflammation, Immunologie et Rhumatologie, Centre de Recherche du CHUL, Université Laval, Québec, Canada.

    2008-2012:  Deputy Head, School of Molecular & Biomedical Science, The University of Adelaide, South Australia.

    2009-2012:  Deputy Executive Dean, Faculty of Sciences, The University of Adelaide, South Australia

    2012-present:  Director, The Centre for Molecular Pathology, The University of Adelaide, South Australia.

    Professor McColl has made a number of important contributions in the area of the genetic and molecular control of cell migration.  These include seminal observations relating to chemotactic factor receptor signal transduction, particularly cytokine- and chemokine-induced phosphorylation cascades and gene expression, the identification of chemokine receptor antagonists that regulate cell migration and the identification of chemokine receptors that are involved in pathologies such as autoimmune diseases and metastatic cancer. His laboratory home page can be found here.

    Professor McColl has received numerous awards and scholarships since commencing his Ph.D. studies in 1984, and is regularly invited to present his work at national and international conferences, at national and international institutions, and at pharmaceutical and biotechnological companies. He has supervised over 25 Honours students, 14 PhD students and 10 Post-Doctoral Fellows. Since 1989, at which time he took up his first academic appointment at Laval University in Quèbec, he has held over $20,000,000 in grants from peer-reviewed funding bodies in Australia, Canada and the USA. He has authored over 120 original articles in peer-reviewed journals and books since 1986.

    Professor McColl served for 5 years as an Associate Editor at the Journal of Immunology, including as a Primary Editor, and reviews manuscripts for a range of other international journals including Nature, American Journal of Pathology, Proceedings of the National Academy of Sciences (USA) and Blood, as well as national and international funding bodies. His research contribution has been recognised in industry and he has consulted for biotechnology and pharmaceutical companies, including Millenium Biosciences in 1999 and Pfizer Central Research, Groton, Connecticut, USA from 1994-1999.  He has served on NH&MRC GRPs from 2003-2006, as Deputy-Chair on GRP2a in 2006, as panel selector for GRP2a and GRP2b in 2007 and as a reviewer assigner for GRP2a in 2008.  He served on NH&MRC Program Grant Review panels in 2010. He is a past member of the Research Advisory Group for the Cancer Council of South Australia.

    In addition to his research, Professor McColl has strongly contributed to capacity building in research in Australia. His laboratory consistently attracts outstanding students.  Since 1995 he has supervised over 30 Honours students, and all but three have achieved First Class Honours.  Eleven have been the top Honours graduate in the School of Molecular & Biomedical Science and 2 have been the top Honours graduate in the University.  He has supervised many outstanding Ph.D. students who have won University Medals for their thesis. He currently supervises 7 HDR students. According to bibliometric analyses on 122 listed articles using the ISI Web of Science, on February 24th 2013, Professor McColl’s total citation count is 6,484 with an average citation rate of almost 55 per paper.  His H Index is 50.  He has been cited over 200 times per year 15 times and over 150 times per year 18 times since 1994.  

     

  • Qualifications

    B.Sc. The University of Adelaide 1981

    B.Sc. Hons. The University of Adelaide 1982

    Ph.D. The University of Adelaide 1988

    D.Sc. The University of Adelaide 2013

    F.FSc. Royal College of Pathologists of Australia 2013

     

  • Media Expertise

    CategoriesMedicine & Medical Research, Science & Technology
    ExpertiseRheumatoid arthritis (molecular biology of, especially the role of chemokine networks in acute and chronic inflammatory processes); proteomics (study of proteins, links with cancer and other diseases); MS; multiple sclerosis; autoimmune diseases (molecular biology of, especially the role of chemokine networks in acute and chronic inflammatory processes); proteins (study of proteins, links with cancer and other diseases)
    NotesAlt phone: (08) 83134259
    Mobile0414 303 425

The information in this directory is provided to support the academic, administrative and business activities of the University of Adelaide. To facilitate these activities, entries in the University Phone Directory are not limited to University employees. The use of information provided here for any other purpose, including the sending of unsolicited commercial material via email or any other electronic format, is strictly prohibited. The University reserves the right to recover all costs incurred in the event of breach of this policy.

Entry last updated: Sunday, 3 Oct 2021